1
|
Kelsen DP, Van de Velde CJH and Minsky BD:
Gastric cancer: clinical management. Principles and Practice of
Gastrointestinal Oncology. Kelsen DP, Daly JM, Kern SE, Levin B,
Tepper JE and Van Cutsem E: 2nd edition. Wolters Kluwer Health,
Lippincott Williams & Wilkins; Philadelphia: pp. 285–316.
2008
|
2
|
Kim MM, Rana V, Janjan NA, et al: Clinical
benefit of palliative radiation therapy in advanced gastric cancer.
Acta Oncol. 47:421–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Tey J, Back MF, Shakespeare TP, et al: The
role of palliative radiation therapy in symptomatic locally
advanced gastric cancer. Int J Radiat Oncol Biol Phys. 67:385–388.
2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chaw CL, Niblock PG, Chaw CS, et al: The
role of palliative radiotherapy for haemostasis in unresectable
gastric cancer: a single-institution experience.
Ecancermedicalscience. 8:3842014.PubMed/NCBI
|
5
|
Hashimoto K, Mayahara H, Takashima A, et
al: Palliative radiation therapy for hemorrhage of unresectable
gastric cancer: a single institute experience. J Cancer Res Clin
Oncol. 135:1117–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Lee JA, Lim do H, Park W, et al: Radiation
therapy for gastric cancer bleeding. Tumori. 95:726–730.
2009.PubMed/NCBI
|
7
|
Asakura H, Hashimoto T, Harada H, et al:
Palliative radiotherapy for bleeding from advanced gastric cancer:
is a schedule of 30 Gy in 10 fractions adequate? J Cancer Res Clin
Oncol. 137:125–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wydmanski J, Suwinski R, Poltorak S, et
al: The tolerance and efficacy of preoperative chemoradiotherapy
followed by gastrectomy in operable gastric cancer, a phase II
study. Radiother Oncol. 82:132–136. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Fowler JF: The linear-quadratic formula
and progress in fractionated radiotherapy. Br J Radiol. 62:679–694.
1989. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wydmanski J and Mohanti BK: An appraisal
of radiation therapy techniques for adjuvant and neoadjuvant
therapy in gastric cancer. J Radiother Pract. 7:67–75. 2008.
View Article : Google Scholar
|
11
|
National Cancer Institute. Common
terminology criteria for adverse events v3.0 (CTCAE). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf#search=“ctcae version 3.0”"ref-label" rowspan="1" colspan="1">
12
|
Suzuki A, Xiao L, Taketa T, et al:
Localized gastric cancer treated with chemoradation without
surgery: UTMD Anderson Cancer Center experience. Oncology.
82:347–351. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Saikawa Y, Kubota T, Kumagai K, et al:
Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin
for inoperable advanced gastric cancer. Int J Radiat Oncol Biol
Phys. 71:173–179. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ajani JA, Mansfield PF, Janjan N, et al:
Multi-institutional trial of preoperative chemoradiotherapy in
patients with potentially resectable gastric carcinoma. J Clin
Oncol. 22:2774–2780. 2004. View Article : Google Scholar
|
15
|
Ajani JA, Mansfield PF, Crane CH, et al:
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma:
degree of pathologic response and not clinical parameters dictated
patient outcome. J Clin Oncol. 23:1237–1244. 2005. View Article : Google Scholar
|
16
|
Allal AS, Zwahlen D, Brundler MA, et al:
Neoadjuvant radiochemotherapy for locally advanced gastric cancer:
long-term results of a phase I trial. Int J Radiat Oncol Biol Phys.
63:1286–1289. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Balandraud P, Moutardier V, Giovannini M,
et al: Locally advanced adenocarcinomas of the gastric cardia:
results of pre-operative chemoradiotherapy. Gastroenterol Clin
Biol. 28:651–657. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lowy AM, Feig BW, Janjan N, et al: A pilot
study of preoperative chemoradiotherapy for resectable gastric
cancer. Ann Surg Oncol. 8:519–524. 2001. View Article : Google Scholar : PubMed/NCBI
|